Buying Ozempic online: important risks to be aware of

GLP-1s, peptides and biohacking for weight loss

Peptides are short chains of amino acids that act as signalling molecules in the body and help regulate many biological processes, including metabolism, appetite and hormone release. Several peptide-based medicines are used in modern healthcare to treat different conditions, including obesity and type 2 diabetes.

GLP-1 receptor agonists, such as semaglutide, and related medicines such as tirzepatide, affect the way the body regulates appetite and blood sugar by mimicking or enhancing the effects of naturally occurring gut hormones. These treatments have shown good results in the treatment of obesity and have attracted considerable attention both in healthcare and on social media.

As interest has grown, different forms of so-called “biohacking” for weight loss have also become popular on platforms such as TikTok and online forums. The term has no clear medical definition and is often used to describe attempts to influence the body’s biological functions using supplements, peptides or medicines outside established healthcare. In some cases, advice is shared about using unapproved substances without medical supervision.

The illegal online trade in medicines

The UK has strict rules governing the authorisation, manufacture and supply of medicines. Prescription medicines should only be supplied through appropriately regulated services and pharmacies, including when they are sold online.

Buying medicines such as Wegovy or Ozempic from unregulated online sellers can carry significant health risks. Counterfeit medicines may contain the wrong dose, no active ingredient at all or completely different substances from those stated on the packaging. Counterfeit GLP-1 medicines seized by authorities have, in some cases, been found to contain insulin or other unknown substances, which can lead to serious complications such as severe hypoglycaemia (low blood sugar).

The Medicines and Healthcare products Regulatory Agency (MHRA) has warned people in the UK about counterfeit and illegally supplied GLP-1 medicines sold through unregulated websites and social media. Some of these sellers may be designed to look like legitimate online pharmacies, using professional-looking websites, payment options and branding to appear trustworthy. As the contents of these products cannot be reliably verified, they may provide no intended treatment effect and could pose serious health risks.

GLP-1 medicines are prescription-only medicines in the UK and should be used following an individual medical assessment and with appropriate ongoing medical follow-up. Safe treatment depends on appropriate prescribing and monitoring, with medicines supplied through legitimate, regulated pharmacies and healthcare providers.

“Research peptides”: what does this mean?

Products claiming to contain substances such as semaglutide or tirzepatide are sometimes sold online as “research peptides” or “for research use only”. These products are often labelled “not for human consumption” or “for laboratory use only”, meaning they are not authorised medicines for human use.

These products are often sold outside the regulated medicines supply chain and are not subject to the same requirements for quality, safety, sterility and traceability as authorised medicines. They will generally not have undergone the quality controls, regulatory assessment and oversight required by UK medicines regulators such as the Medicines and Healthcare products Regulatory Agency (MHRA).

There is therefore no reliable guarantee that the contents match the label, that the stated concentration is accurate or that the product is free from contaminants or manufacturing residues. Using unregulated injectable products can carry serious health risks, including infection, incorrect dosing, allergic reactions and other potentially serious complications.

Medicines used to treat obesity and type 2 diabetes should always be used as part of evidence-based healthcare, following an individual medical assessment and with ongoing follow-up from healthcare professionals.

The health risks of counterfeit Ozempic and unregulated peptides

Using medicines or injectable products bought outside the regulated pharmacy and healthcare system can carry significant health risks. Medicines regulators and customs authorities internationally have reported seizures of counterfeit GLP-1 medicines that, in some cases, contained insulin or other unknown substances instead of semaglutide or tirzepatide.

Accidentally taking insulin when it is not medically required can cause severe hypoglycaemia (low blood sugar). In serious cases, this can lead to loss of consciousness, seizures and potentially life-threatening emergencies requiring immediate medical attention.

Even products that do contain a GLP-1-based substance may carry risks when used without an appropriate medical assessment and follow-up. GLP-1-based medicines affect appetite regulation, gastrointestinal function and metabolism, among other processes. Treatment is generally increased gradually according to the relevant dosing schedule to help reduce side effects such as nausea, vomiting and diarrhoea.

Before treatment begins, a medical assessment is normally carried out to identify potential risk factors or conditions that may require particular consideration, such as a history of pancreatitis, gallstones or certain gastrointestinal conditions.

Because unregulated products lack reliable quality assurance and medical oversight, there is no guarantee about their contents, dose, sterility or safety. Medicines used to treat obesity should therefore be prescribed and used within regulated, evidence-based healthcare and with appropriate medical supervision.

What is “Ozempil” or “Ozempill”?

“Ozempil” and “Ozempill” have quickly become common search terms, but there is no authorised medicine with either name. The term combines the medicine name Ozempic with the English word “pill” and is often used when searching for Ozempic or semaglutide in tablet form. Semaglutide tablets are not new. The active ingredient is already available as Rybelsus, a medicine authorised for the treatment of type 2 diabetes.

Oral semaglutide formulations for weight management are a newer development. Their authorisation and availability can differ between countries, so people in the UK should check the current UK-approved indication and availability rather than relying on information about launches or approvals elsewhere in Europe.

It is also important to be cautious when searching for terms such as “Ozempil”. As this is not the name of an authorised medicine, unregulated websites may use the term to advertise counterfeit or unauthorised products. Prescription medicines should be sold under their correct names and supplied through regulated pharmacies.

How to recognise a legitimate online pharmacy

Ozempic and other medicines containing semaglutide are prescription-only medicines in the UK. A legitimate online pharmacy will therefore require an appropriate prescription before supplying these medicines.

If a website offers Ozempic or similar prescription medicines without a prescription or appropriate medical assessment, this is a clear warning sign that the seller may not be operating within UK medicines regulations.

In Great Britain, you can check whether an online pharmacy is registered by searching the General Pharmaceutical Council (GPhC) register. You can also check the MHRA’s guidance on buying medicines online for information on how to identify potentially unsafe or illegal sellers.

Legitimate online healthcare and pharmacy services also use appropriate processes to confirm your identity, assess whether a prescription medicine is suitable for you and ensure that it is supplied safely.

How Yazen provides safe, evidence-based GLP-1 treatment

At Yazen, treatment with GLP-1-based medicines is provided as part of evidence-based care, with ongoing medical follow-up. Treatment begins with an individual medical assessment that takes into account your medical history, current medicines, risk factors and relevant blood tests to determine whether treatment is appropriate and safe for you.

Obesity is a chronic and complex condition that requires long-term treatment and follow-up. The aim of treatment is therefore not just weight loss, but also to support metabolic health, quality of life and long-term weight stability.

Throughout treatment, you are regularly followed up by qualified healthcare professionals. Your dose and treatment plan are tailored to you based on how well the treatment is working, how well you tolerate it and any side effects, with the aim of using the lowest effective dose where clinically appropriate.

Treatment also includes support with nutrition, physical activity and behaviour change. With a multidisciplinary team including doctors, dietitians and other healthcare professionals, you receive structured support designed to help you make sustainable changes over time.

Frequently asked questions about peptides, biohacking and counterfeit medicines

What is the difference between authorised GLP-1 medicines and research peptides?

Authorised medicines such as Ozempic, Wegovy and Mounjaro have undergone extensive clinical trials to assess their effectiveness, safety, dosing and side effects before being authorised by medicines regulators such as the Medicines and Healthcare products Regulatory Agency (MHRA). They are manufactured under strictly regulated conditions, with rigorous requirements for quality, sterility and traceability.

So-called “research peptides” sold through unregulated websites, on the other hand, are not authorised medicines for human use. They are often marketed as “for research use only” or “not for human consumption” and are not subject to the same requirements for safety, quality control or regulatory oversight.

This means their contents, concentration and purity may be unknown. They may contain incorrect doses, contaminants or substances that are not stated on the label. As they are manufactured and distributed outside the regulated medicines supply chain, there is also no reliable guarantee of sterility or safe handling.

Treatment with GLP-1-based medicines should therefore use appropriately authorised medicines, following a medical assessment and with ongoing medical supervision.

Can I legally buy Ozempic online without a prescription?

No. Ozempic is a prescription-only medicine in the UK and cannot legally be supplied without a valid prescription from an appropriately qualified prescriber.

Websites or sellers offering Ozempic, Wegovy or Mounjaro without an appropriate medical assessment and prescription may be operating outside UK medicines regulations. UK regulators warn that medicines bought from unregulated sellers may be counterfeit, contain incorrect doses or include substances that are not stated on the packaging.

Treatment with GLP-1 medicines should always follow an individual medical assessment and include appropriate medical follow-up to make sure the treatment is suitable based on your health and any relevant risk factors.

What happens if you accidentally take counterfeit Ozempic?

Counterfeit medicines can pose serious health risks because their contents may be unknown and are not subject to appropriate quality controls. In some cases, a counterfeit product may contain no active ingredient at all, meaning it will not have the intended treatment effect. Medicines regulators internationally have also reported counterfeit GLP-1 medicines containing insulin or other undeclared substances.

If someone who does not need insulin takes it accidentally, it can cause hypoglycaemia (low blood sugar). Symptoms can develop quickly and may include sweating, a fast heartbeat, confusion and loss of consciousness. In severe cases, it can cause seizures or a life-threatening medical emergency requiring immediate treatment.

Because counterfeit products are manufactured outside the regulated medicines supply chain, there is also a risk of incorrect dosing, contamination, poor sterility and unknown chemicals. This means there is no reliable way to know what the product contains or how your body may react.

To reduce these risks, GLP-1 medicines should always be obtained from a regulated pharmacy and used following a medical assessment and with appropriate medical follow-up.

Why are peptides for weight loss sold so cheaply on the unregulated market?

Products sold through unregulated websites are not subject to the same requirements as authorised medicines. Unlike authorised medicines, these products will generally not have undergone the clinical trials, quality controls or regulatory assessment required for medicines.

Authorised medicines require extensive research, controlled manufacturing and appropriate medical oversight to ensure their quality, effectiveness and safety. Unregulated products often bypass these safeguards, which is one reason they may be sold at much lower prices.

Is medical follow-up included when I receive a prescription from Yazen?

Yes. Medical follow-up is a key part of Yazen’s treatment model. Treatment begins with an individual medical assessment that includes a review of your medical history, current medicines and relevant health information before any treatment is prescribed.

Throughout treatment, you receive ongoing follow-up from qualified healthcare professionals. Depending on your individual needs and treatment plan, this may include monitoring your blood pressure, weight, blood test results, side effects and general health.

Medicines are prescribed and supplied through regulated channels, and your treatment is adjusted over time based on effectiveness, tolerability and your individual medical needs. The aim is to provide safe, evidence-based and sustainable long-term treatment for overweight and obesity.

Sources

General Pharmaceutical Council (GPhC). Buying medicines safely online.
https://www.pharmacyregulation.org/patients-and-public/standards-you-can-expect-using-pharmacy-services/buying-medicines-safely-online

World Health Organization. Substandard and falsified medical products.
https://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products

European Medicines Agency (EMA). Beware of falsified medicines bought online.
https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/falsified-medicines